Shared Stories
Preclinical & Clinical Research Studies and More
Read stories about the exciting work our customers are doing, including preclinical research studies and clinical research studies using Vevo imaging systems.
Accurate endoscopic detection of dysplasia in patients with Barrett’s esophagus (BE) remains a major clinical challenge. Hence, there is a clinical need for a rapid in vivo wide-field imaging method to identify dysplasia in BE, with the capability to image beyond the mucosal layer. Read more.
The screening method of ultrasound-based techniques combined with CA125 tests is promising for early detection of ovarian cancer.
We used Vevo technology to periodically assess left ventricle function during aging and to determine the stage of worst disease condition at which we harvested the heart and performed papillary muscle studies. Read more.
There is an urgent need to identify first trimester pregnancies at risk for the development of preeclampsia—a leading cause of maternal and perinatal mortality—in order to improve clinical treatment of the disease.
Hypoxia, a deficiency in the amount of oxygen reaching tissue, plays a central role in poor HCC outcomes. ccumulating evidence shows that up to 50-60% of locally advanced solid tumors may exhibit heterogeneously distributed hypoxic (and anoxic) areas within the tumor mass. Read more.
The fundamental goal of basic science (pre-clinical) research is to translate what we learn in cells and animal models to human physiology and human disease states. Today, it's not uncommon to hear terms such as “Knowledge Translation” and “Translational Research”. Read more.
Using the VevoLAZR to Characterize the Tumor Microenvironment and Develop Innovative Contrast Agents
Molecular Imaging is emerging as an innovative and multidisciplinary field of research aimed at visualizing and quantifying the signature of diseases, making it possible for an earlier and more precise diagnosis. Read more.
Intracerebral hemorrhages (ICH) is a cause of stroke for which no effective drug therapy exists. Our work investigates a novel mouse model of ICH with high frequency ultrasound (US) and photoacoustics for long-term screening of potential preclinical therapeutics. Read more.
New, ultra high frequency (UHF) ultrasound techniques enable visualisation of the separate layers of the vessel wall. This allows us to establish in which part of the vessel wall the initial changes appear, as well as possibly identifying changes at an earlier stage than with the composite measurement of IMT by conventional methods.
At the Mouse Imaging Centre of the Hospital for Sick Children in Toronto, we have collaborated with VisualSonics Inc. since early 2000 and used their products from the very first generation to the most advanced versions. Read more.